{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:11:55Z","timestamp":1782961915339,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["SAF2009-12422-C02-01"],"award-info":[{"award-number":["SAF2009-12422-C02-01"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["SAF 2012-40075-C02-01"],"award-info":[{"award-number":["SAF 2012-40075-C02-01"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.10.016","type":"journal-article","created":{"date-parts":[[2014,10,19]],"date-time":"2014-10-19T15:29:44Z","timestamp":1413732584000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain"],"prefix":"10.1016","volume":"745","author":[{"given":"Ana","family":"Bag\u00fc\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"S\u00e1nchez-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.10.016_bib1","first-page":"191","article-title":"Experimental stressors alter hypertonic saline-evoked masseter muscle pain and autonomic response","volume":"26","author":"Bendixen","year":"2012","journal-title":"J. Orofac. Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2009.06.009","article-title":"Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception","volume":"105","author":"Booker","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2014.10.016_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2014.10.016_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpain.2009.02.003","article-title":"Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests","volume":"14","author":"Burgos","year":"2010","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pain.2004.04.033","article-title":"Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection","volume":"110","author":"Capra","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2007.09.099","article-title":"The expression of receptors for endocannabinoids in human and rodent skeletal muscle","volume":"364","author":"Cavuoto","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.10.016_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2007.05.024","article-title":"The antinociceptive effect of delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor","volume":"570","author":"Cox","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta(9)-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.10.016_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/cmdc.201100568","article-title":"Chromenopyrazoles: non-psychoactive and selective CB1 cannabinoid agonists with peripheral antinociceptive properties","volume":"7","author":"Cumella","year":"2012","journal-title":"Chemmedchem"},{"key":"10.1016\/j.ejphar.2014.10.016_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib11","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.ejphar.2014.10.016_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejphar.2014.10.016_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjp.0706984","article-title":"Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis","volume":"150","author":"Gutierrez","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib15","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.pain.2011.03.038","article-title":"Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain","volume":"152","author":"Gutierrez","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1124\/jpet.103.060079","article-title":"Selective activation of cannabinoid CB2 receptors suppresses hyperalgesia evoked by intradermal capsaicin","volume":"308","author":"Hohmann","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.10.016_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors RID B-7358-2011 RID E-1312-2011","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2014.10.016_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2010.03.071","article-title":"Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze","volume":"475","author":"Huang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.10.016_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.ejphar.2014.10.016_bib20","first-page":"627","article-title":"Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain. Naunyn-Schmiedeberg\u05f3s Arch","volume":"379","author":"Leichsenring","year":"2009","journal-title":"Pharmacol"},{"key":"10.1016\/j.ejphar.2014.10.016_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2007.04.019","article-title":"The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain","volume":"53","author":"Liang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.10.016_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00023210-200822080-00003","article-title":"Role of cannabinoids in the management of neuropathic pain","volume":"22","author":"Martin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2014.10.016_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(99)00479-3","article-title":"Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception","volume":"378","author":"Mason","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1440-1681.2010.05346.x","article-title":"Peripheral antinociceptive effect of 2-arachidonoyl-glycerol and its interaction with endomorphin-1 in arthritic rat ankle joints","volume":"37","author":"Mecs","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90134-X","article-title":"Tonic Analgesic Effects of Delta-9-Tetrahydrocannabinol as Measured with the Formalin Test","volume":"61","author":"Moss","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pain.2010.07.027","article-title":"Bilateral activation of the trigeminothalamic tract by acute orofacial cutaneous and muscle pain in humans","volume":"151","author":"Nash","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.pain.2012.07.037","article-title":"Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats","volume":"153","author":"Niu","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.10.016_bib29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1476-5381.1992.tb09088.x","article-title":"Inhibitory Effects of Certain Enantiomeric Cannabinoids in the Mouse Vas-Deferens and the Myenteric Plexus Preparation of Guinea-Pig Small-Intestine","volume":"105","author":"Pertwee","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib30","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond., B, Biol. Sci."},{"key":"10.1016\/j.ejphar.2014.10.016_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3959(03)00005-8","article-title":"Development of a behavioral assessment of craniofacial muscle pain in lightly anesthetized rats","volume":"104","author":"Ro","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/j.1532-2149.2012.00115.x","article-title":"Cannabinoids and muscular pain. Effectiveness of the local administration in rat","author":"Sanchez Robles","year":"2012","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.ejphar.2014.10.016_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pbb.2010.07.009","article-title":"Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models","volume":"96","author":"Sanchez","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.10.016_bib35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/ern.11.47","article-title":"THC and CBD oromucosal spray (Sativex (R)) in the management of spasticity associated with multiple sclerosis","volume":"11","author":"Sastre-Garriga","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.ejphar.2014.10.016_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00415-012-6634-z","article-title":"Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis","volume":"260","author":"Serpell","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib37","series-title":"Orofacial Pain","first-page":"131","author":"Sessle","year":"2005"},{"key":"10.1016\/j.ejphar.2014.10.016_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","article-title":"Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats","volume":"60","author":"Smith","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.10.016_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor \u2013 Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.10.016_bib40","first-page":"2772","article-title":"[Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis \u2013 secondary publication]","volume":"167","author":"Svendsen","year":"2005","journal-title":"Ugeskr. Laeger"},{"key":"10.1016\/j.ejphar.2014.10.016_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.archoralbio.2006.11.015","article-title":"What can human experimental pain models teach us about clinical TMD?","volume":"52","author":"Svensson","year":"2007","journal-title":"Arch. Oral Biol"},{"key":"10.1016\/j.ejphar.2014.10.016_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures \u2013 a short review","volume":"90","author":"Svizenska","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.10.016_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0091-3057(03)00151-5","article-title":"Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors","volume":"75","author":"Takahashi","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2014.10.016_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000324070","article-title":"Cannabinoids for pain management","volume":"30","author":"Thaler","year":"2011","journal-title":"Chronic Pain Addict."},{"key":"10.1016\/j.ejphar.2014.10.016_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","article-title":"Sex differences in antinociceptive and motoric effects of cannabinoids","volume":"430","author":"Tseng","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib46","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.pain.2013.02.007","article-title":"Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models","volume":"154","author":"Vincenzi","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5055\/jom.2006.0026","article-title":"A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008 \u2013 a long-acting, parenteral opioid analgesic \u2013 in the treatment of postherpetic neuralgia","volume":"2","author":"Wallace","year":"2006","journal-title":"J. Opioid. Manag."},{"key":"10.1016\/j.ejphar.2014.10.016_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.anes.0000286986.92475.b7","article-title":"Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers","volume":"107","author":"Wallace","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2014.10.016_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2010.07.019","article-title":"A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain","volume":"151","author":"Yu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2014.10.016_bib50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1476-5381.2009.00184.x","article-title":"Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain","volume":"157","author":"Zhu","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.10.016_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/fcp.12008","article-title":"The role of endocannabinoids in pain modulation","volume":"27","author":"Zogopoulos","year":"2013","journal-title":"Fundam. Clin. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914007237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T10:34:15Z","timestamp":1589279655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914007237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"alternative-id":["S0014299914007237"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}